Here, we present a case of a 6-year-old girl diagnosed with refractory ITP, who failed to respond to standard therapies but showed a remarkable clinical improvement with avatrombopag, a thrombopoietin receptor agonist. The gene discussed is MPL; the disease is autoimmune thrombocytopenic purpura.